Syndax Pharmaceuticals, Inc. (SNDX)
19.38
-0.13
(-0.67%)
USD |
NASDAQ |
Dec 10, 10:27
Syndax Pharmaceuticals Total Assets (Quarterly): 551.79M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arcutis Biotherapeutics, Inc. | 370.98M |
| ACADIA Pharmaceuticals, Inc. | 1.331B |
| Verastem, Inc. | 176.85M |
| Puma Biotechnology, Inc. | 202.86M |
| Krystal Biotech, Inc. | 1.240B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 436.36M |
| Shareholders Equity (Quarterly) | 115.43M |
| Debt to Equity Ratio | 2.993 |
| Current Ratio | 4.64 |
| Net Debt Paydown Yield | -5.15% |